
MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. (INKT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INKT · as of Jun 9, 2026
Key Statistics
Explore MiNK Therapeutics, Inc. Data
inkt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The INKT analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $35.00, representing +208.64% upside from the current price of $11.34.
Competitors & Peers
inkt competitorsStock Performance
Full HistoryAbout MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natur…
what is mink therapeutics, inc. · inkt stock overview · mink therapeutics, inc. company profile · who is mink therapeutics, inc. ceo · inkt NASDAQ · mink therapeutics, inc. headquarters · mink therapeutics, inc. business segments
About Stock Overview & Key Data
MiNK Therapeutics, Inc. (INKT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 15, 2021. As of the latest trading session, INKT stock price is $11.34, with a market capitalization of $56.5M. The stock has returned +58.38% over the past 12 months and +1.70% year-to-date.
According to 5 Wall Street analysts, the consensus rating for MiNK Therapeutics, Inc. stock is Buy, with an average 12-month price target of $35.00. In fiscal year 2025, MiNK Therapeutics, Inc. reported revenue of — and net income of -$12.5M. For detailed data — including MiNK Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MiNK Therapeutics, Inc. (INKT) stock price is $11.34. The stock is traded on NASDAQ under the ticker symbol INKT. The 52-week range is $6.80 – $76.00.